Profile data is unavailable for this security.
About the company
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices. The Sports Medicine Joint Repair franchise offers surgeons a range of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, including the repair of soft tissue injuries and degenerative conditions of the knee, hip and shoulder. The AET franchise offers an array of minimally invasive surgery-enabling systems and devices. The Trauma & Extremities franchise supports healthcare professionals with solutions used by surgeons to stabilize severe fractures, correct bone deformities, treat arthritis and heal soft tissue complications.
- Revenue in GBP (TTM)3.30bn
- Net income in GBP323.94m
- Incorporated1937
- Employees17.91k
- LocationSmith & Nephew PLCBuilding 5, Croxley Park, Hatters LaneWATFORD WD18 8YEUnited KingdomGBR
- Phone+44 207 401 7646
- Fax+44 207 930 3353
- Websitehttp://www.smith-nephew.com/
More ▼
Mergers & acquisitions
| Acquired company | SN.:LSE since announced | Transaction value |
|---|---|---|
| Integra LifeSciences Holdings Corp-Extremity Orthopedics Business | -3.87% | 240.00m |
Data delayed at least 20 minutes, as of Apr 19 2021 10:43 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cellink AB | 31.68m | -3.69m | 2.57bn | 215.00 | -- | 12.83 | 9,046.83 | 81.17 | -1.05 | -1.05 | 8.25 | 42.67 | 0.2366 | 0.9019 | 3.21 | 1,718,968.00 | -2.81 | -- | -3.00 | -- | 85.48 | -- | -11.86 | -- | 6.36 | -19.40 | 0.047 | -- | -- | -- | -- | -- | -- | -- |
| Elekta AB (publ) | 1.21bn | 113.22m | 3.71bn | 4.13k | 33.93 | 5.46 | 16.94 | 3.07 | 3.46 | 3.46 | 36.91 | 21.49 | 0.5564 | 3.05 | 2.68 | 3,425,796.00 | 5.20 | 3.45 | 9.55 | 6.24 | 41.87 | 42.03 | 9.35 | 6.33 | 1.09 | 7.62 | 0.4537 | 54.96 | 7.72 | 6.14 | -9.52 | 14.45 | -4.95 | 29.20 |
| ConvaTec Group PLC | 1.37bn | 81.35m | 4.12bn | 9.69k | 50.74 | 3.41 | 18.39 | 3.01 | 0.0406 | 0.0406 | 0.6826 | 0.6027 | 0.5136 | 3.02 | 6.14 | 141,367.70 | 3.05 | 1.47 | 3.48 | 1.63 | 53.78 | 53.67 | 5.94 | 3.00 | 1.72 | 4.00 | 0.481 | 165.15 | 3.67 | 2.79 | 1,047.96 | -- | 18.05 | -- |
| Getinge AB | 2.56bn | 277.62m | 5.82bn | 10.82k | 22.49 | 3.46 | 12.40 | 2.28 | 11.89 | 11.89 | 109.48 | 77.19 | 0.6647 | 3.28 | 5.11 | 2,756,425.00 | 7.30 | 2.23 | 9.47 | 2.99 | 49.39 | 47.39 | 10.98 | 4.18 | 1.32 | 17.34 | 0.3151 | 46.79 | 12.27 | -0.2767 | 165.06 | 18.43 | -12.64 | 1.68 |
| Amplifon SpA | 1.35bn | 87.52m | 6.94bn | 11.27k | 79.72 | 9.93 | 26.70 | 5.15 | 0.444 | 0.444 | 6.86 | 3.56 | 0.5117 | 19.64 | 8.11 | 138,086.40 | 3.32 | 4.63 | 4.32 | 6.14 | 22.97 | 54.35 | 6.50 | 6.73 | 1.17 | 6.16 | 0.6616 | 25.59 | -10.19 | 8.51 | -7.05 | 16.63 | 4.81 | 38.61 |
| Demant A/S | 1.69bn | 130.59m | 8.54bn | 16.16k | 65.15 | 8.86 | 34.19 | 5.07 | 4.68 | 4.68 | 60.34 | 34.39 | 0.6618 | 2.16 | 4.59 | 895,636.00 | 5.19 | 8.54 | 8.26 | 13.79 | 71.46 | 75.25 | 7.84 | 11.17 | 0.64 | 8.88 | 0.521 | 0.00 | -3.19 | 6.29 | -23.32 | -4.83 | 5.23 | -- |
| Ambu A/S | 445.01m | 33.78m | 8.82bn | 4.20k | 291.83 | 35.12 | 158.76 | 19.82 | 1.16 | 1.16 | 15.29 | 9.66 | 0.7858 | 2.63 | 7.61 | 912,347.80 | 5.97 | 8.38 | 7.15 | 10.70 | 63.27 | 58.45 | 7.59 | 10.77 | 1.05 | 5.11 | 0.4391 | 30.08 | 26.49 | 13.56 | -23.97 | 9.66 | 32.83 | 8.83 |
| GN Store Nord A/S | 1.57bn | 145.85m | 9.04bn | 6.53k | 56.70 | 13.58 | 33.72 | 5.77 | 9.62 | 9.62 | 103.43 | 40.15 | 0.8062 | 4.06 | 4.90 | 2,061,149.00 | 7.61 | 9.08 | 10.85 | 11.98 | 54.26 | 59.90 | 9.44 | 11.29 | 0.9535 | 108.73 | 0.5307 | 18.18 | 6.96 | 11.64 | -13.89 | 10.88 | 9.72 | 7.93 |
| Carl Zeiss Meditec AG | 1.16bn | 112.55m | 11.35bn | 3.29k | 100.48 | -- | -- | 9.82 | 1.46 | 1.46 | 14.93 | -- | -- | -- | -- | 405,669.30 | -- | 7.94 | -- | 9.96 | 55.93 | 55.46 | 9.82 | 10.17 | -- | 7.06 | -- | 36.70 | -8.49 | 5.13 | -23.39 | 14.46 | 21.81 | 5.64 |
| Smith & Nephew plc | 3.30bn | 323.94m | 12.66bn | 17.91k | 39.12 | 3.30 | 17.34 | 3.84 | 0.3682 | 0.3682 | 3.75 | 4.36 | 0.449 | 0.8448 | 3.59 | 184,057.10 | 4.41 | 7.91 | 5.25 | 9.57 | 69.39 | 72.89 | 9.82 | 13.70 | 1.76 | 11.02 | 0.4114 | 46.96 | -11.25 | -0.3214 | -25.33 | 1.79 | 4.35 | -5.59 |
| Sonova Holding AG | 2.01bn | 331.66m | 13.41bn | 14.35k | 39.64 | 7.36 | 27.44 | 6.67 | 6.69 | 5.26 | 40.57 | 36.02 | 0.5138 | 2.82 | 6.30 | 168,611.70 | 8.52 | 10.57 | 10.70 | 13.27 | 70.87 | 69.92 | 16.58 | 15.59 | 2.26 | 33.46 | 0.4467 | 32.87 | 5.56 | 7.47 | -7.71 | 3.09 | 7.68 | -- |
| Straumann Holding AG | 1.12bn | 71.72m | 15.60bn | 7.02k | 220.21 | 16.47 | 103.58 | 13.93 | 5.67 | 5.67 | 89.54 | 75.81 | 0.5774 | 1.76 | 4.24 | 203,257.50 | 3.74 | 13.46 | 4.65 | 16.25 | 72.22 | 75.29 | 6.47 | 18.55 | 2.47 | 7.61 | 0.3652 | 34.41 | -10.67 | 12.29 | -70.22 | 5.25 | 18.46 | 7.53 |
| Coloplast A/S | 2.16bn | 494.05m | 22.93bn | 12.50k | 50.00 | 36.65 | 38.70 | 10.60 | 19.88 | 19.88 | 87.04 | 27.12 | 1.32 | 2.88 | 6.30 | 1,494,327.00 | 30.13 | 31.57 | 61.83 | 54.57 | 67.88 | 67.88 | 22.84 | 22.68 | 0.5666 | 17.46 | 0.447 | 89.51 | 3.37 | 5.92 | 8.37 | 36.09 | 8.58 | 7.57 |
Data as of Apr 19 2021. Currency figures normalised to Smith & Nephew PLC's reporting currency: UK Pound GBX
24.62%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Wellington Management Co. LLPas of 31 Dec 2020 | 42.67m | 4.85% |
| WCM Investment Management LLCas of 03 Mar 2020 | 33.98m | 3.87% |
| BlackRock Fund Advisorsas of 12 Feb 2021 | 24.77m | 2.82% |
| The Vanguard Group, Inc.as of 01 Apr 2021 | 22.18m | 2.52% |
| Norges Bank Investment Managementas of 01 Apr 2021 | 19.99m | 2.27% |
| Walter Scott & Partners Ltd.as of 01 Apr 2021 | 18.91m | 2.15% |
| Rathbone Investment Management Ltd.as of 01 Apr 2021 | 16.14m | 1.84% |
| Fidelity Management & Research Co. LLCas of 01 Apr 2021 | 13.29m | 1.51% |
| State Street Global Advisors Ltd.as of 01 Apr 2021 | 12.78m | 1.45% |
| Schroder Investment Management Ltd.as of 01 Apr 2021 | 11.71m | 1.33% |
More ▼
Data from 31 Dec 2020 - 15 Apr 2021Source: FactSet Research Systems Inc.
